US Stock MarketDetailed Quotes

RVPH Reviva Pharmaceuticals

Watchlist
  • 1.040
  • -0.060-5.45%
Close Mar 21 16:00 ET
  • 1.070
  • +0.030+2.87%
Post 18:50 ET
48.44MMarket Cap-0.96P/E (TTM)

Reviva Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Reviva Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Reviva Pharmaceuticals Earnings Reports

  • 8-K: Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 14, 2024 17:31 ET

  • 10-Q: Q3 2024 Earnings Report

    Nov 14, 2024 17:21 ET

  • 10-Q: Q2 2024 Earnings Report

    Aug 14, 2024 08:19 ET

  • 8-K: Reviva Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 14, 2024 08:14 ET

    • Read more

    Market Insights
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +14.85%
    New Fortress Energy
    NFE
    +7.92%
    Cars.com
    CARS
    +2.11%
    Halozyme Therapeutics
    HALO
    +1.31%
    Collegium Pharmaceutical
    COLL
    +0.40%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 30, 2025

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data